Back to search
FDAFDA · Food and drugs·Recall number Z-2935-2026

Straumann Bone Level Tapered (BLT) Implant, D 4.1mm RC, SLActive 14mm, Roxolid, Loxim (Article 021.5314); implant, endosseous, root-form

Published August 19, 2026 · Recall initiated: July 16, 2026

Summary

FDA records medical device Class II recall Z-2935-2026, published August 19, 2026 and initiated July 16, 2026. Recalling firm: Straumann USA LLC; Status: Ongoing; Reported quantity: 175 units; Lot: UDI/DI 7630031707055, Lot ZVFV5. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Bone Level Tapered (BLT) Implant, D 4.1mm RC, SLActive 14mm, Roxolid, Loxim may inadvertently contain implants that are 12mm in length instead of 14mm as the labeling would suggest.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Straumann USA LLC
Distributor
US Nationwide distribution.
Lot
UDI/DI 7630031707055, Lot ZVFV5
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Straumann Bone Level Tapered (BLT) Implant, D 4.1mm RC, SLActive 14mm, Roxolid, Loxim (Article 021.5314); implant, endosseous, root-form recalled?

Yes. FDA published recall Z-2935-2026 on August 19, 2026. Reported hazard: Bone Level Tapered (BLT) Implant, D 4.1mm RC, SLActive 14mm, Roxolid, Loxim may inadvertently contain implants that are 12mm in length instead of 14mm as the labeling would suggest.

What should I do if I have this product?

Voluntary: Firm initiated · Letter